孟鲁司特钠联合布地奈德和异丙托溴铵雾化吸入治疗小儿感染后咳嗽的效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect of Montelukast Sodium combined with Budesonide and Ipratropium Bromide nebulization in the treatment of infantile cough after infection.Methods A total of 68 children with cough after infection in our hospital from January 2016 to December 2017 were selected as the observation subjects,they were divided into two groups according to random number table method,namely,the control group (n=34),experimental group (n=34).The patients in the control group were given Montelukast Sodium orally,and those in the experimental group were treated with Budesonide and Ipratropium Bromide atomization inhalation on the basis of the control group.The clinical curative effect,improvement of symptoms and the adverse reaction rates were compared statistically.Results The clinical total effective rate of the experimental group was significantly higher than that of the control group.The data were 94.12%and 76.47%,and the difference was statistically significant(P＜0.05）.After treatment,the scores of cough and sleep in the experimental group were significantly lower than that in the control group,and the differences were statistically significant(P＜0.05）.The incidence of adverse reactions in the experimental group was 5.88%,and the incidence of adverse reactions in the control group was 2.94%,and the difference was not statistically significant(P＞0.05）.Conclusion The clinical effect of Montelukast Sodium combined with Budesonide and Ipratropium Bromide atomization inhalation is more accurate.It can effectively improve the quality of cough and sleep in children with safe and reliable characteristics.

Key words： Infantile infection Cough Montelukast Sodium Budesonide Ipratropium Bromide

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	KAN Yu-fang
	CHENG Jun
	LI Feng-qin

Cite this article:

KAN Yu-fang,CHENG Jun,LI Feng-qin. Efficacy of Montelukast Sodium combined with Budesonide and Ipratropium Bromide in the treatment of cough after infantile infection[J]. 中国当代医药, 2018, 25(15): 105-107.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I15/105

[1]	王志刚，朱阿瑾，张金玉，等.孟鲁司特钠联合布地奈德治疗小儿肺炎支原体感染慢性咳嗽效果分析[J].中国校医，2017，31（12）：909，911.
[2]	中华医学会儿科学分会呼吸学组慢性咳嗽协作组.中国儿童慢性咳嗽诊断与治疗指南（2013年修订）[J].中华儿科杂志，2014，52（3）：184-188.
[3]	郭旭伟，李书婷.雾化吸入联合孟鲁司特治疗小儿感染后咳嗽疗效[J].疾病监测与控制，2017，11（9）：746-747.
[4]	周庆.孟鲁斯特钠片与异丙托溴铵和布地奈德混悬液雾化吸入对小儿呼吸道感染性咳嗽的临床疗效评价[J].抗感染药学，2017，14（5）：1010-1012.
[5]	潘俊文.布地奈德联合盐酸氨溴索雾化吸入对小儿肺炎支原体感染所致慢性咳嗽的影响分析[J].中国医药指南，2017，15（17）：152-153.
[6]	林玉婵，林宁，冯真英，等.雾化吸入联合孟鲁斯特钠咀嚼片治疗小儿感染后咳嗽疗效评价[J].中国医药科学，2017，7（10）：42-45.
[7]	吴曼林，吴顺明，余永良.布地奈德与复方异丙托溴铵溶液雾化吸入治疗对小儿呼吸道感染后咳嗽的临床疗效评价[J].抗感染药学，2017，14（2）：426-428.
[8]	张淑云.布地奈德联合异丙托溴铵治疗小儿毛细支气管炎疗效观察[J].海峡药学，2017，29（4）：128-129.
[9]	刘金红.用异丙托溴铵、沙丁胺醇和布地奈德治疗小儿毛细支气管炎的效果评析[J].当代医药论丛，2016，14（24）：73-74.
[10]	刘海楠，柳晓艳，郭红云.不同药物雾化吸入治疗小儿毛细支气管炎临床疗效分析[J].慢性病学杂志，2016，17（8）：925-927.
[11]	张蓓.布地奈德和复方异丙托溴铵雾化吸入联合孟鲁斯特治疗小儿感染后咳嗽的效果分析[J].中国现代药物应用，2016，10（16）：148-149.
[12]	章光栋.布地奈德、特布他林、异丙托溴铵联合雾化吸入治疗小儿支气管肺炎疗效观察[J].中国处方药，2016，14（1）：94-95.
[13]	茅志萍.布地奈德、复方异丙托溴铵雾化吸入辅治小儿肺炎支原体感染后慢性咳嗽60例的疗效分析[J].数理医药学杂志，2015，28（10）：1512-1513.
[14]	宋雷.吸入用异丙托溴铵雾化溶液与布地奈德联合雾化治疗小儿毛细支气管炎的临床疗效观察[J].中国现代药物应用，2015，9（14）：146-147.
[15]	王潇娉，廖友明，万忠和.布地奈德混悬液联合异丙托溴铵雾化治疗小儿支气管肺炎的疗效分析[J].现代诊断与治疗，2015，26（2）：337-338.